Free WCG Foundation webinars offer insights on speeding access to experimental drugs for intermediate-size patient populations

Presenters include Richard Klein, formerly of FDA, and Marjorie Speers of WCGF ATLANTA, Ga.,  Jan. 9, 2018—WCG Foundation will host free webinars Jan. 25 and Feb. 5 on how to streamline the application process for experimental medications for intermediate-size populations of desperately ill patients. The webinars—“Intermediate-Size Patient Populations INDs: What Are They, When Should They [...]

January 9, 2018|News|0 Comments

One patient’s story: How WCGF helped speed approval for experimental treatment

It took more than two years for Tyson Fowler to receive an accurate diagnosis of the cause of his motor neuron symptoms. By then, chronic Lyme disease had taken its toll. The once healthy, athletic 30-something was confined to a wheelchair, unable to move on his own. His condition was worsening rapidly, and the prognosis was grim.

December 6, 2017|News|0 Comments

WCG Foundation receives $50,000 from Johnson & Johnson

PRINCETON, N.J. Nov. 7, 2017—WCG Foundation has received $50,000 from Johnson & Johnson to help desperately ill patients get access to experimental medicines.

The gift supports WCGF’s efforts to help patients navigate the Food and Drug Administration’s expanded access program, which makes investigational drugs available to patients who have exhausted all other treatment and clinical trial options.

Learn More >

November 7, 2017|News|Comments Off on WCG Foundation receives $50,000 from Johnson & Johnson